-+ 0.00%
-+ 0.00%
-+ 0.00%

Germany's BioNTech Names New CEO

MT Newswires·08/03/2026 23:41:13
Listen to the news
11:41 PM EDT, 08/03/2026 (MT Newswires) -- German biopharmaceutical company BioNTech (22UA.F) appointed Guido Oelkers as its new chief executive officer to succeed Ugur Sahin, effective Feb. 1, 2027. Oelkers served as the CEO of Swedish pharmaceutical company Swedish Orphan Biovitrum (SOBI.ST), or Sobi, according to a Monday release.